[Skip to Navigation]
Sign In
Invited Commentary
July 2017

Metastasectomy for Abdominal Visceral Oligometastatic Melanoma

Author Affiliations
  • 1Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
JAMA Surg. 2017;152(7):678. doi:10.1001/jamasurg.2017.0460

In the era of targeted immunotherapy for stage IV melanoma, there is general agreement that patients with isolated abdominal metastases should be treated with resection if they can be rendered no evidence of disease. Similarly, there is little debate that patients with substantial disease burden should be offered palliative metastasectomy only in cases of bleeding, obstruction, or pain to address their symptoms.1 We agree with the conclusion of Deutsch et al2 supporting the importance of surgical resection in selected patients with abdominal metastases from melanoma and congratulate the authors on compiling their institutional experience with an impressive number of patients and long-term follow-up.2

Add or change institution